Timeline

Voting rights breakdown

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

• ADDEX THERAPEUTICS LTD19.73%
• 9 shareholders holding less than 3% of the voting rights19.73%

Notice details

Beneficial owner

ADDEX THERAPEUTICS LTD

The disclosure of this shareholdings is triggered by the constitution of a lock-up Group disclosed in the prospectus linked to the capital increase processed on January 8 2021 and published in the SHAB on January 12 2021. Addex Therapeutics Ltd : the lock-up agreement terminates on March 8,2021 Board and executive members: the lock-up agreement terminates on April 7, 2021